MNKD MANNKIND CORP
Nasdaq · SEC CIK 899460 · EDGAR
- Bought, last 12 months
- $259.0K 1 purchases by 1 insiders
- Sold, last 12 months
- $3.13M 12 sales by 5 insiders
- Filings on record
- 247 since 2021-08-02, latest 2026-09-14 20:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Castagna Michael | CEO, Dir | $259.0K | $1.25M |
| Thomson David | EVP Genl Counsel, Sec | — | $930.8K |
| Binder Steven B. | Dir | — | $555.2K |
| Tross Stuart A | Chief People, Workpl Off | — | $297.5K |
| Singh Sanjay R | EVP Technical Ops | — | $94.4K |
| Ahuja Ajay | Chief Medical Off | — | — |
| Marasco Dominic | Pres, Endocrine Business Unit | — | — |
| Prentiss Christopher B | CFO | — | — |
| Shannon James Samuel | Dir | — | — |
| HOOPER ANTHONY C | Dir | — | — |
Transactions 258
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-29 | 2022-08-27 | MNKD | Tross Stuart A | Chief People, Workpl Off | F - Tax | $3.73 | -14.2K | 816.5K | -2% | -$52.9K | |
| 2022-08-29 | 2022-08-29 | MNKD | Thomson David | EVP Genl Counsel, Sec | S - Sale | $3.67 | -7,000 | 726.0K | -1.0% | -$25.7K | |
| 2022-08-29 | 2022-08-27 | MNKD | Thomson David | EVP Genl Counsel, Sec | F - Tax | $3.73 | -14.2K | 733.0K | -2% | -$52.9K | |
| 2022-08-29 | 2022-08-27 | MNKD | Kocinsky Joseph | CTO | F - Tax | $3.73 | -12.8K | 745.2K | -2% | -$47.8K | |
| 2022-08-29 | 2022-08-27 | MNKD | Castagna Michael | CEO, Dir | F - Tax | $3.73 | -36.0K | 2.05M | -2% | -$134.1K | |
| A | 2022-08-24 | 2022-02-28 | MNKD | Tross Stuart A | Chief People, Workpl Off | A - Grant | $2.71 | +9,225 | 632.0K | +1% | +$25.0K |
| A | 2022-08-24 | 2022-07-31 | MNKD | Binder Steven B. | CFO | A - Grant | $2.93 | +791 | 729.0K | +0.1% | +$2,318 |
| A | 2022-08-24 | 2022-02-28 | MNKD | Galindo Alejandro | EVP Endocrine Business Unit | A - Grant | $2.71 | +36.9K | 576.7K | +7% | +$100.0K |
| A | 2022-08-24 | 2022-02-28 | MNKD | Castagna Michael | CEO, Dir | A - Grant | $2.71 | +27.7K | 1.53M | +2% | +$75.0K |
| A | 2022-08-24 | 2022-07-31 | MNKD | Castagna Michael | CEO, Dir | A - Grant | $2.93 | +3,147 | 2.08M | +0.2% | +$9,221 |
| A | 2022-08-24 | 2022-01-31 | MNKD | Castagna Michael | CEO, Dir | A - Grant | $3.17 | +1,804 | 1.51M | +0.1% | +$5,719 |
| A | 2022-08-24 | 2022-01-31 | MNKD | Binder Steven B. | CFO | A - Grant | $3.17 | +711 | 534.2K | +0.1% | +$2,254 |
| A | 2022-08-24 | 2022-01-31 | MNKD | Tross Stuart A | Chief People, Workpl Off | A - Grant | $3.17 | +2,254 | 622.8K | +0.4% | +$7,145 |
| A | 2022-08-24 | 2022-07-31 | MNKD | Tross Stuart A | Chief People, Workpl Off | A - Grant | $2.93 | +4,581 | 830.6K | +0.6% | +$13.4K |
| A | 2022-08-24 | 2022-01-31 | MNKD | Galindo Alejandro | EVP Endocrine Business Unit | A - Grant | $3.17 | +1,804 | 539.8K | +0.3% | +$5,719 |
| A | 2022-08-24 | 2022-07-31 | MNKD | Galindo Alejandro | EVP Endocrine Business Unit | A - Grant | $2.93 | +5,000 | 781.7K | +0.6% | +$14.7K |
| M | 2022-08-23 | 2022-08-22 | MNKD | Galindo Alejandro | EVP Endocrine Business Unit | S - Sale | $3.85 | -4,615 | 777.1K | -0.6% | -$17.8K |
| 2022-08-01 | 2022-07-31 | MNKD | Castagna Michael | CEO, Dir | P - Purchase | $2.93 | +3,147 | 2.08M | +0.2% | +$9,221 | |
| 2022-08-01 | 2022-07-31 | MNKD | Galindo Alejandro | EVP Endocrine Business Unit | P - Purchase | $2.93 | +5,000 | 781.7K | +0.6% | +$14.7K | |
| 2022-08-01 | 2022-07-31 | MNKD | Binder Steven B. | CFO | P - Purchase | $2.93 | +791 | 729.0K | +0.1% | +$2,318 | |
| 2022-08-01 | 2022-07-31 | MNKD | Tross Stuart A | Chief People, Workpl Off | P - Purchase | $2.93 | +4,581 | 830.6K | +0.6% | +$13.4K | |
| A | 2022-05-25 | 2022-05-18 | MNKD | Galindo Alejandro | EVP Endocrine Business Unit | I - Discretionary | $3.19 | +4,789 | 776.7K | +0.6% | +$15.3K |
| 2022-05-20 | 2022-05-18 | MNKD | Castagna Michael | CEO, Dir | F - Tax | $3.19 | -16.4K | 2.08M | -0.8% | -$52.4K | |
| 2022-05-20 | 2022-05-18 | MNKD | Thomson David | EVP Genl Counsel, Sec | F - Tax | $3.19 | -6,001 | 747.2K | -0.8% | -$19.1K | |
| 2022-05-20 | 2022-05-18 | MNKD | Kocinsky Joseph | CTO | F - Tax | $3.19 | -5,383 | 758.0K | -0.7% | -$17.2K | |
| 2022-05-20 | 2022-05-18 | MNKD | Galindo Alejandro | EVP Endocrine Business Unit | F - Tax | $3.19 | -4,789 | 771.9K | -0.6% | -$15.3K | |
| 2022-05-20 | 2022-05-18 | MNKD | Binder Steven B. | CFO | F - Tax | $3.19 | -5,972 | 728.2K | -0.8% | -$19.1K | |
| 2022-05-20 | 2022-05-18 | MNKD | Tross Stuart A | Chief People, Workpl Off | F - Tax | $3.19 | -5,941 | 826.1K | -0.7% | -$19.0K | |
| M | 2022-05-12 | 2022-05-10 | MNKD | Galindo Alejandro | EVP Endocrine Business Unit | A - Grant | $0.00 | +200.0K | 666.7K | +43% | $0 |
| M | 2022-05-12 | 2022-05-10 | MNKD | Thomson David | EVP Genl Counsel, Sec | A - Grant | $0.00 | +200.0K | 753.2K | +36% | $0 |
| M | 2022-05-12 | 2022-05-10 | MNKD | Kocinsky Joseph | CTO | A - Grant | $0.00 | +200.0K | 763.4K | +35% | $0 |
| M | 2022-05-12 | 2022-05-10 | MNKD | Castagna Michael | CEO, Dir | A - Grant | $0.00 | +565.0K | 1.79M | +46% | $0 |
| M | 2022-05-12 | 2022-05-10 | MNKD | Binder Steven B. | CFO | A - Grant | $0.00 | +200.0K | 624.2K | +47% | $0 |
| M | 2022-05-12 | 2022-05-10 | MNKD | Tross Stuart A | Chief People, Workpl Off | A - Grant | $0.00 | +200.0K | 832.0K | +32% | $0 |
| 2022-03-01 | 2022-02-28 | MNKD | MUNDKUR CHRISTINE | Dir | P - Purchase | $2.71 | +27.7K | 254.5K | +12% | +$75.0K | |
| 2022-03-01 | 2022-02-28 | MNKD | Castagna Michael | CEO, Dir | P - Purchase | $2.71 | +27.7K | 1.53M | +2% | +$75.0K | |
| 2022-03-01 | 2022-02-28 | MNKD | HOOPER ANTHONY C | Dir | P - Purchase | $2.71 | +40.0K | 338.4K | +13% | +$108.4K | |
| 2022-03-01 | 2022-02-28 | MNKD | Galindo Alejandro | Chief Commercial Off | P - Purchase | $2.71 | +36.9K | 576.7K | +7% | +$100.0K | |
| 2022-03-01 | 2022-02-28 | MNKD | Grancio Jennifer | Dir | P - Purchase | $2.71 | +110.7K | 244.8K | +83% | +$300.0K | |
| 2022-03-01 | 2022-02-28 | MNKD | Tross Stuart A | Chief People, Workpl Off | P - Purchase | $2.71 | +9,225 | 632.0K | +1% | +$25.0K | |
| A | 2022-02-09 | 2022-01-31 | MNKD | Tross Stuart A | Chief People, Workpl Off | P - Purchase | $3.17 | +2,254 | 622.8K | +0.4% | +$7,145 |
| A | 2022-02-09 | 2022-01-31 | MNKD | Galindo Alejandro | Chief Commercial Off | P - Purchase | $3.17 | +1,804 | 539.8K | +0.3% | +$5,719 |
| A | 2022-02-09 | 2022-01-31 | MNKD | Castagna Michael | CEO, Dir | P - Purchase | $3.17 | +1,804 | 1.51M | +0.1% | +$5,719 |
| 2022-02-02 | 2022-01-31 | MNKD | Tross Stuart A | Chief People, Workpl Off | P - Purchase | $3.17 | +4,254 | 624.8K | +0.7% | +$13.5K | |
| 2022-02-02 | 2022-01-31 | MNKD | Binder Steven B. | CFO | P - Purchase | $3.17 | +711 | 534.2K | +0.1% | +$2,254 | |
| 2022-02-02 | 2022-01-31 | MNKD | Castagna Michael | CEO, Dir | P - Purchase | $3.17 | +2,334 | 1.51M | +0.2% | +$7,399 | |
| 2022-02-02 | 2022-01-31 | MNKD | Galindo Alejandro | Chief Commercial Off | P - Purchase | $3.17 | +2,334 | 540.3K | +0.4% | +$7,399 | |
| 2021-08-27 | 2021-08-27 | MNKD | Thomson David | EVP Genl Counsel, Sec | S - Sale | $4.64 | -4,100 | 567.4K | -0.7% | -$19.0K | |
| 2021-08-27 | 2021-08-27 | MNKD | Thomson David | EVP Genl Counsel, Sec | F - Tax | $4.91 | -14.2K | 553.2K | -2% | -$69.6K | |
| 2021-08-27 | 2021-08-27 | MNKD | Galindo Alejandro | Chief Commercial Off | F - Tax | $4.91 | -9,616 | 538.0K | -2% | -$47.2K | |
| 2021-08-27 | 2021-08-27 | MNKD | Tross Stuart A | Chief People, Workpl Off | F - Tax | $4.91 | -14.2K | 620.5K | -2% | -$69.6K | |
| 2021-08-27 | 2021-08-27 | MNKD | Castagna Michael | CEO, Dir | F - Tax | $4.91 | -35.4K | 1.50M | -2% | -$173.6K | |
| 2021-08-27 | 2021-08-27 | MNKD | Kocinsky Joseph | CTO | F - Tax | $4.91 | -9,983 | 563.4K | -2% | -$49.0K | |
| 2021-08-27 | 2021-08-27 | MNKD | Binder Steven B. | CFO | F - Tax | $4.91 | -14.2K | 533.5K | -3% | -$69.6K | |
| 2021-08-02 | 2021-07-30 | MNKD | Galindo Alejandro | Chief Commercial Off | P - Purchase | $2.99 | +5,000 | 547.6K | +0.9% | +$15.0K | |
| 2021-08-02 | 2021-07-30 | MNKD | Tross Stuart A | Chief People, Workpl Off | P - Purchase | $2.99 | +4,476 | 634.7K | +0.7% | +$13.4K | |
| 2021-08-02 | 2021-07-30 | MNKD | Binder Steven B. | CFO | P - Purchase | $2.99 | +748 | 547.6K | +0.1% | +$2,237 | |
| 2021-08-02 | 2021-07-30 | MNKD | Castagna Michael | CEO, Dir | P - Purchase | $2.99 | +5,000 | 1.54M | +0.3% | +$15.0K |
Purchase Sale Sale after option exercise All abbreviations